No shortage on file

WIXELA INHUB

MYLAN PHARMACEUTICALS ULC

Quick answers

Is there a shortage of WIXELA INHUB in Canada?

No. There is no current shortage of WIXELA INHUB 500MCG 50MCG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

DIN

02495619

Strength

500MCG 50MCG

Dosage Form

POWDER

Route

INHALATION

Active Ingredient

FLUTICASONE PROPIONATE SALMETEROL

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-08-25

Resolved

Disruption of the manufacture of the drug.

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

40MG · DIN 02257963

10MG · DIN 02257955

DIN 02388138

DIN 02388146

FULVESTRANT INJECTION

50MG · DIN 02468549

GEMCITABINE FOR INJECTION, USP

2G · DIN 02407310

GEMCITABINE FOR INJECTION, USP

1G · DIN 02407302

GEN-CLOZAPINE

12.5MG · DIN 02554631

GEN-CLOZAPINE

100MG · DIN 02247244

GEN-CLOZAPINE

25MG · DIN 02247243